in recent years we have witnessed increased reliance on 2 modalities in the management of patients with superficial transitional cell cancer of the bladder , that is intravesical chemotherapy for the control of existing and recurrent disease , and urinary cytology for the diagnosis of persistent or new neoplastic cells .
C0279680
transitional cell cancer of the bladder
C0597032
neoplastic